4th Quarter - Report — GILEAD SCIENCES, INC. for GILEAD SCIENCES INC (2017)

Firm

GILEAD SCIENCES, INC.

Client

GILEAD SCIENCES INC

Income

—

Expenses

$900,000

Expense method

A: Lobbying Disclosure Act definitions

What was lobbied

9 issue areas, each in the filer's own words, with who lobbied on it and where.

Trade (domestic/foreign) TRD

International trade and protection of intellectual property

Lobbyist	Covered position, as disclosed
CHARLES M. CLAPTON	—
KACY HUTCHISON	—
DAVID PULLIAM	—

Contacted: Natl Security Council (NSC); HOUSE OF REPRESENTATIVES; Natl Economic Council (NEC); SENATE; State, Dept of (DOS); Health & Human Services, Dept of (HHS); U.S. Trade Representative (USTR)

Taxation/Internal Revenue Code TAX

Tax Cuts and Jobs Act of 2017 (P.L. 115-97)

Lobbyist	Covered position, as disclosed
CHARLES M. CLAPTON	—
KACY HUTCHISON	—
DAVID PULLIAM	—

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Natl Security Council (NSC); State, Dept of (DOS); Natl Economic Council (NEC); Health & Human Services, Dept of (HHS); U.S. Trade Representative (USTR)

Copyright/Patent/Trademark CPT

Technology transfer, patent rights and funding, patent reform legislation. Issues related to pharmaceuticals and intellectual property protection.

Lobbyist	Covered position, as disclosed
CHARLES M. CLAPTON	—
KACY HUTCHISON	—
DAVID PULLIAM	—

Contacted: State, Dept of (DOS); Health & Human Services, Dept of (HHS); U.S. Trade Representative (USTR); SENATE; Natl Economic Council (NEC); HOUSE OF REPRESENTATIVES; Natl Security Council (NSC)

Health Issues HCR

Pending healthcare legislation and potential impact on the biopharmaceutical industry. Ryan White Care Act reauthorization; Hepatitis C policy; PEPFAR reauthorization; HIV/AIDS research, testing and treatment. HCV screening and linkage to care programs; coverage and reimbursement policy for HCV and HIV portfolio. Funding for HCV and public health activities via appropriations. Pharmaceutical policy as it relates to payments under the 340B program; implementation of section 340B drug discount program. Prison population and hepatitis C. International trade and protection of intellectual property.

Lobbyist	Covered position, as disclosed
CHARLES M. CLAPTON	—
KACY HUTCHISON	—
DAVID PULLIAM	—

Contacted: SENATE; Health & Human Services, Dept of (HHS); Natl Security Council (NSC); Natl Economic Council (NEC); HOUSE OF REPRESENTATIVES; State, Dept of (DOS); U.S. Trade Representative (USTR)

Medicare/Medicaid MMM

HCV testing, screening and linkage to care programs. Federal program coverage, access and reimbursement issues for Hepatitis C, HIV, and oncology products. Coverage of pharmaceuticals, cost-sharing and other access issues; issues related to coverage and reimbursement of pharmaceuticals. Medicaid duplicate discounts.

Lobbyist	Covered position, as disclosed
CHARLES M. CLAPTON	—
KACY HUTCHISON	—
DAVID PULLIAM	—

Contacted: State, Dept of (DOS); Natl Security Council (NSC); U.S. Trade Representative (USTR); SENATE; HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Natl Economic Council (NEC)

Budget/Appropriations BUD

Funding for HCV and public health activities via appropriations. Pharmaceutical policy as it relates to payments under the 340B program.

Lobbyist	Covered position, as disclosed
CHARLES M. CLAPTON	—
KACY HUTCHISON	—
DAVID PULLIAM	—

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); U.S. Trade Representative (USTR); State, Dept of (DOS); Natl Security Council (NSC); Natl Economic Council (NEC)

Indian/Native American Affairs IND

Education related to Hepatitis C in American Indian population.

Lobbyist	Covered position, as disclosed
CHARLES M. CLAPTON	—
DAVID PULLIAM	—

Contacted: HOUSE OF REPRESENTATIVES; U.S. Trade Representative (USTR); Natl Security Council (NSC); Health & Human Services, Dept of (HHS); SENATE; Natl Economic Council (NEC); State, Dept of (DOS)

Veterans VET

Education related to Hepatitis C. FY18 Military Construction VA Appropriations bill.

Lobbyist	Covered position, as disclosed
CHARLES M. CLAPTON	—
DAVID PULLIAM	—

Contacted: U.S. Trade Representative (USTR); Natl Economic Council (NEC); HOUSE OF REPRESENTATIVES; SENATE; Natl Security Council (NSC); State, Dept of (DOS); Health & Human Services, Dept of (HHS)

Foreign Relations FOR

Issues related to pharmaceuticals and international finance for health services. Access to medicines and intellectual property protection.

Lobbyist	Covered position, as disclosed
CHARLES M. CLAPTON	—
KACY HUTCHISON	—
DAVID PULLIAM	—

Contacted: Health & Human Services, Dept of (HHS); Natl Security Council (NSC); U.S. Trade Representative (USTR); SENATE; HOUSE OF REPRESENTATIVES; State, Dept of (DOS); Natl Economic Council (NEC)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.